Their platform represents an important opportunity to reimagine clinical trial design through simulation, and we're excited to explore this capability together.
Emmanuel Frenehard
Chief Digital Officer, Sanofi
Proud to Work with
Reality vs Simulation
A simulation that consists of diverse, real-world patients, each with a unique response profile to your investigational therapy that closely approximates actual likely response.
KM analysis of progression-free survival in a multiple myeloma trial for 1L patients
Use Cases
Supporting Sponsors from Early Clinical Development to Approval
Clinical Development
- Protocol Optimization
- Indication Selection
- TPP
- PTS
- Market Forecasting
- Enrollment Prediction
Business Development
- Search and Evaluation - Many to Few
- Comparative Deep Dive - Few to One
- Asset Diligence & Valuation
- Asset Out-licensing & Disposition
Portfolio Management
- Portfolio Prioritization
- Inter-portfolio Synergy and Competition
- Portfolio Gaps and Opportunities
Optimizing Clinical Outcomes With
Enrollment and Market in Mind
Protocol Optimization
Optimize your clinical trial protocol with critical inputs that allow you to refine key criteria, such as:
-
Highly nuanced inclusion and exclusion criteria
-
Investigational arm – regimen, combination, dosage, arm size
-
Any control arm – SoC, placebo, competitor
-
Outcomes and endpoints
Outcome Predictions
Make data-driven and more effective clinical trial design decisions based on in-depth virtual trial results that mirror the depth and precision of actual trial data.
Enrollment Prediction
Predict recruitment curves by combining protocol cohort definitions with site-level data, enabling researchers to compare expected enrollment rates across cohorts.
Market Forecasting
Make more informed, strategic decisions with patient counts predicted across geographical markets and compared across cohorts, based on a specific cohort definition.
Demonstrating Value Across Therapeutic Areas
Case Studies by Disease Type
Acute Respiratory Disease
AI-based clinical and operational optimization enabling cost reductions and improved likelihood of success
Read Report
MASH
Cutting edge clinical trial design: combining AI-driven clinical optimization with population PK-PD
Read Report
Head & Neck Cancer
AI-based clinical optimization of an Antibody-Drug Conjugate in metastatic HNSCC to maximize clinical trial success
Read Report
Inflammatory Bowel Disease
AI-based clinical prioritization of a portfolio of potential assets for inflammatory bowel disease to maximize portfolio ROI
Read Report
